Logo
Make a donation
Make a donation

Sylvie Chevret’s team – Biostatistics and clinical epidemiology

...

Sylvie Chevret

Team leader

Institut de recherche Saint-Louis

View the service

Courriel
Stéphanie CHAMBAUD

Research themes

By combining the activities of the research unit with expertise in data management and statistics, the department provides answers to questions raised by investigators through research protocols.

By developing new statistical methods or improving existing ones, the department contributes to improving patient care and, more broadly, to strengthening public health.

Sylvie Chevret's team members

Souad BENARAB
Data manager
Cendrine CHAFFAUT
Biostatistician
Kristell DESSEAUX
Biostatistician
Corinne NYANOU
Data manager
Claire PACHECO
Data manager
Emilia STAN
Bioinformatician
Anouk WALTER PETRICH
Biostatistician
Brigitte GUILLON
Data scientist
Noémie BIGOT
Biostatistician
Clémence GUILHIN
Research Engineer
Valentin VINNAT
Research Engineer
Olivier HASSANALY
Data scientist
Andrei BONTE
Network Administrator
Déborah AZOULAY
Secretary/Administrative Manager
Hélène BATIGA
Data entry operator

Scientific publications

A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

Déborah Meyran & al, Haematologica, 2024

A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Read the publication
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia (en translation)

Yves Chalandon & al, Blood, 2024

Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia
Read the publication
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study

Pierre Hirsch & al, Blood Cancer J, 2024

Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
Read the publication

Clinical studies

Observational cohort study of patients aged over 60 years with acute myeloid leukemia (AML) receiving standard chemotherapy treatment with idarubicin-cytarabine

Combination of anti-PD1 antibody with reinfusion of Tisagenlecleucel in children, adolescents, and young adults with acute lymphoblastic leukemia

Phase 3 study comparing sequential induction chemotherapy with sequential conditional induction chemotherapy in patients with acute myeloid leukemia in the CBF group

Treatment protocol for standard-risk B-cell acute lymphoblastic leukemia in children

Multicenter protocol for the treatment of acute lymphoblastic leukemia (ALL) in young adults (18-59) – GRAALL 2005-GRAALL-R GRAAPH 2005

Evaluation of residual disease in cryopreserved ovarian fragments prior to allogeneic hematopoietic stem cell transplantation in patients in complete remission from acute leukemia.

Clono-specific residual disease in acute myeloid leukemia

National protocol for the treatment of acute lymphoblastic leukemia (ALL) in children and adolescents

Study of the expansion and persistence of anti-CD19 CAR-T lymphocytes (CTL019) using HIV PCR during treatment of relapsed or refractory pediatric B-cell acute lymphoblastic leukemia

Randomized Phase III study of Decitabine with or without Hydrea versus Hydrea alone in patients with advanced chronic myelomonocytic leukemia

Acute Myeloid Leukemia: Retrospective Real-World Clinical and Biological Database, Updated

Primary plasma cell leukemias: a phase II prospective study combining Daratamumab with chemotherapy and intensive treatment plus autologous transplantation

Join us

Every year, we welcome interns from master’s programs and engineering schools specializing in:

Biostatistics, Computer Science,

Risk Management and Financial Engineering,

AI Computer Science,

Applied Mathematics,

Biological Engineering.

Join us